Literature DB >> 4427418

Reduced in vitro binding of tryptophan by plasma in uremia.

A de Torrente, G B Glazer, P Gulyassy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4427418     DOI： 10.1038/ki.1974.103

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Cerebral transmitter precursors and metabolites in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

3.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 4.  The binding of drugs to plasma proteins from patients with poor renal function.

Authors:  M M Reidenberg
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

5.  Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia.

Authors:  D M Lichtenwalner; B Suh; M R Lichtenwalner
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

6.  Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

7.  Brain transmitter precursors and metabolites in diabetic ketoacidosis.

Authors:  G Curzon; B D Kantamaneni; N Callaghan; P A Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-06       Impact factor: 10.154

8.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

9.  Diverse community leaders' perspectives about quality primary healthcare and healthcare measurement: Qualitative community-based participatory research.

Authors:  Kathleen A Culhane-Pera; Shannon L Pergament; Maiyia Y Kasouaher; Andrew M Pattock; Naima Dhore; Cindy N Kaigama; Marcela Alison; Michael Scandrett; Mai See Thao; David J Satin
Journal:  Int J Equity Health       Date:  2021-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.